Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies

REFERENCES

1. 1.↵
   1. Vitali C,
   2. Bombardieri S,
   3. Jonsson R,
   4. Moutsopoulos HM,
   5. Alexander EL,
   6. Carsons SE,
   7. et al.

   Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–8.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Shiboski SC,
   2. Shiboski CH,
   3. Criswell L,
   4. Baer A,
   5. Challacombe S,
   6. Lanfranchi H,
   7. et al.

   American College of Rheumatology Classification Criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance Cohort. Arthritis Care Res 2012;64:475–87.

   OpenUrlCrossRef
3. 3.↵
   1. Tzioufas AG,
   2. Tatouli IP,
   3. Moutsopoulos HM

   . Autoantibodies in Sjögren’s syndrome: clinical presentation and regulatory mechanisms. Presse Med 2012;41:e451–60.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Hanejil N,
   2. Nakamura T,
   3. Takio K,
   4. Yanagi K,
   5. Higashiyama H,
   6. Saito I,
   7. et al.

   Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren’s syndrome. Science 1997;276:604–7.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Kobayashi I,
   2. Kawamura N,
   3. Okano M,
   4. Shikano T,
   5. Mizumoto M,
   6. Hayashi Y,
   7. et al.

   Anti-alpha-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren’s syndrome. J Rheumatol 2001;28:363–5.

   OpenUrlAbstract/FREE Full Text
6. 6.
   1. Ruffatti A,
   2. Ostuni P,
   3. Grypiotis P,
   4. Botsios C,
   5. Tonello M,
   6. Grava C,
   7. et al.

   Sensitivity and specificity for primary Sjögren’s syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA. J Rheumatol 2004;31:504–7.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Sordet C,
   2. Gottenberg J,
   3. Goetz J,
   4. Bengoufa D,
   5. Humbel RL,
   6. Mariette X,
   7. et al.

   Anti-α-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren’s syndrome. Ann Rheum Dis 2005;64:1244–5.

   OpenUrlFREE Full Text
8. 8.
   1. Goëb V,
   2. Salle V,
   3. Duhaut P,
   4. Jouen F,
   5. Smail A,
   6. Ducroix JP,
   7. et al.

   Clinical significance of autoantibodies recognizing Sjögren’s syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren’s syndrome. Clin Exp Immunol 2007;148:281–7.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Ruiz T,
   2. Lopez-Longo F,
   3. Santamaría B,
   4. Urrea R,
   5. Carreño L,
   6. Estecha A,
   7. et al.

   Prevalence of IgG anti- α-fodrin antibodies in Sjögren’s syndrome. Ann N Y Acad Sci 2005;1050:210–6.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Willeke P,
    2. Gautbitz M,
    3. Schotte H,
    4. Becker H,
    5. Mickholz E,
    6. Domschke W,
    7. et al.

    Clinical and immunological characteristics of patients with Sjögren’s syndrome in relation to α-fodrin antibodies. Rheumatology 2007;46:479–83.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Watanabe T,
    2. Tsuchida T,
    3. Kanda N,
    4. Mori K,
    5. Hayashi Y,
    6. Tamaki K

    . Anti-α-fodrin antibodies in Sjögren’s syndrome and lupus erythematosus. Arch Dermatol 1999;135:535–9.

    OpenUrlCrossRefPubMed
12. 12.
    1. Zanbelt M,
    2. Vogelzangs J,
    3. van de Puttee L,
    4. Van Venrooij WJ,
    5. Van Den Hoogen FH

    . Anti-α-fodrin antibodies do not add much to the diagnosis of Sjögren’s syndrome. Arthritis Res Ther 2004;6:R33–8.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Tuckcapar N,
    2. Olmez U,
    3. Turkak H,
    4. Duman M

    . The importance of alpha-fodrin antibodies in the diagnosis of Sjögren’s syndrome. Rheumatol Int 2006;26:354–9.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Witte T

    . Antifodrin antibodies in Sjögren’s syndrome. Ann N Y Acad Sci 2005;1051:235–9.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Hu Q,
    2. Wang D,
    3. Chen W

    . The accuracy of the anti-alpha-fodrin antibody test for diagnosis of Sjögren’s syndrome: a meta-analysis. Clin Biochemistry 2013;46:1272–6.

    OpenUrlCrossRef
16. 16.↵
    1. Hernández-Molina G,
    2. Avila-Casado C,
    3. Nuñez-Alvarez C,
    4. Cárdenas-Velázquez F,
    5. Hernández-Hernández C,
    6. Luisa Calderillo M,
    7. et al.

    Utility of the American-European Consensus Group and American College of Rheumatology classification criteria for Sjögren’s syndrome in patients with systemic autoimmune diseases in the clinical setting. Rheumatology 2015;54:441–8.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Vitali C,
    2. Bombardieri S,
    3. Moutsopoulos HM,
    4. Balestrieri G,
    5. Bencivelli W,
    6. Bernstein RM,
    7. et al.

    Preliminary criteria for the classification of Sjögren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340–7.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Sánchez-Guerrero J,
    2. Aguirre E,
    3. Pérez M,
    4. Kraus A,
    5. Cardiel MH,
    6. Soto-Rojas AE

    . The wafer test: a semi-quantitative test to screen for xerostomia. Rheumatology 2002;41:381–9.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Whitcher JP,
    2. Shiboski CH,
    3. Shiboski SC,
    4. Heidenreich AM,
    5. Kitagawa K,
    6. Zhang S,
    7. et al.

    A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s Syndrome International Registry. Am J Ophthalmol 2009;149:405–15.

    OpenUrlPubMed
20. 20.↵
    1. Navazesh M

    . Methods of collecting saliva. Ann N Y Acad Sci 1993;694:72–7.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Saegusa K,
    2. Ishimaru N,
    3. Yanagi K,
    4. Mishima K,
    5. Arakaki R,
    6. Suda T,
    7. et al.

    Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren’s syndrome. J Immunol 2002;169:1050–7.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Yanagi K,
    2. Ishimaru H,
    3. Haneji N,
    4. Saegusa K,
    5. Saito I,
    6. Hayashi Y

    . Anti-120-kDa alpha-fodrin immune response with Th1 cytokine profile in the NOD mouse model of Sjögren’s syndrome. Eur J Immunol 1998;28:336–45.

    OpenUrl
23. 23.↵
    1. Maruyama T,
    2. Saito I,
    3. Hayashi Y,
    4. Kompfner E,
    5. Fox RI,
    6. Burton DR,
    7. et al.

    Molecular analysis of the human autoantibody response to α-fodrin in Sjögren’s syndrome reveals novel apoptosis-induced specificity. Am J Pathol 2004;165:53–61.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Witte T,
    2. Matthias T,
    3. Arnett F,
    4. Peter HH,
    5. Hartung K,
    6. Sachse C,
    7. et al.

    IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren’s syndrome. Systemic lupus erythematosus. J Rheumatol 2000;27:2617–20.

    OpenUrlPubMed
25. 25.↵
    1. Witte T,
    2. Matthias T,
    3. Oppermann M,
    4. Helmke K,
    5. Peter HH,
    6. Schmidt RE,
    7. et al.

    Prevalence of antibodies against alpha-fodrin in Sjögren’s syndrome: comparison of 2 sets of classification criteria. J Rheumatol 2003;30:2157–9.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Qin Q,
    2. Wang H,
    3. Wang AZ,
    4. Huang YL,
    5. Li H,
    6. Zhang WW,
    7. et al.

    Diagnostic accuracy of anti-alpha-fodrin antibodies for primary Sjögren’s syndrome. Mod Rheumatol 2014;24:793–7.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Takahashi K,
    2. Tatsuzawa O,
    3. Yanagi K,
    4. Hayashi Y,
    5. Takahashi H

    . Alpha-fodrin autoantibody in Sjögren’s syndrome and other autoimmune diseases in childhood. Eur J Pediatr 2001;160:520–1.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Maeno N,
    2. Takei S,
    3. Imanaka H,
    4. Oda H,
    5. Yanagi K,
    6. Hayashi Y,
    7. et al.

    Anti-α-fodrin in Sjögren’s syndrome in children. J Rheumatol 2001;28:860–4.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Quartuccio L,
    2. Baldini C,
    3. Bartolini E,
    4. Priori R,
    5. Carubbi F,
    6. Corazza L,
    7. et al.

    Anti-SSA/SSB negative Sjögren’s syndrome shows a lower prevalence of lymphoproliferative manifestations, and lower risk of lymphoma evolution. Autoimmun Rev 2015;14:1019–22.

    OpenUrlCrossRefPubMed
30. 30.↵
    1. de Seze J,
    2. Dubucquoi S,
    3. Fauchais A,
    4. Matthias T,
    5. Devos D,
    6. Castelnovo G,
    7. et al.

    Alpha-fodrin autoantibodies in the differential diagnosis of MS and Sjögren syndrome. Neurology 2003;61:268–9.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Szanto A,
    2. Csipo I,
    3. Horvath I,
    4. Biro E,
    5. Szodoray P,
    6. Zeher M

    . Autoantibodies to alfa-fodrin in patients with Hashimoto thyroiditis and Sjögren’s syndrome: possible markers for a common secretory disorder. Rheumatol Int 2008;11:1169–72.

    OpenUrl
32. 32.↵
    1. Ulbricht KU,
    2. Schmidt RE,
    3. Witte T

    . Antibodies against alpha-fodrin in Sjögren’s syndrome. Autoimmun Rev 2003;2:109–13.

    OpenUrlCrossRefPubMed